Biomedical Co. Clearside Gets OK For $4M Ch. 11 Sale
Eye disease treatment developer Clearside Biomedical received a Delaware bankruptcy judge's approval on Tuesday to sell certain assets for $4 million to its stalking horse....To view the full article, register now.
Already a subscriber? Click here to view full article